首页> 外文期刊>Pathology oncology research: POR >Correlation between immunophenotype classification and clinicopathological features in chinese patients with primary gastric diffuse large B-cell lymphoma.
【24h】

Correlation between immunophenotype classification and clinicopathological features in chinese patients with primary gastric diffuse large B-cell lymphoma.

机译:中国原发性胃弥漫性大B细胞淋巴瘤患者免疫表型分类与临床病理特征的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

Recent studies have shown that diffuse large B-cell lymphoma (DLBCL) can be classified into germinal center B-cell-like (GCB) and non-GCB phenotypes by immunohistochemical staining. The aim of this study was to investigate the correlation of immunophenotypic classification with clinicopathological features in Chinese patients with primary gastric DLBCL to further our knowledge of this disease. Seventy-three patients with a histopathological diagnosis of primary gastric DLBCL were studied. Immunohistochemistry was carried out using the EnVision method to detect the expression of CD10, Bcl-6, and MUM1. The clinicopathologic features and follow-up data were analyzed using the Kaplan-Meier method, log-rank test, and χ (2) test. Expression of CD10 was observed in 21.9?% (16/73) of patients, Bcl-6 in 72.6?% (53/73), and MUM1 in 74.0?% (54/73). According to these data, 32.9?% (24/73) of the cases belonged to GCB subtype and 67.1?% (49/73) belonged to non-GCB subtype. There was a significant difference in tumor size and local lymph node metastasis between the GCB and non-GCB groups (P??0.05). Survival analysis revealed that patients in the GCB group had an increased 5-year survival rate compared to those in the non-GCB group (58.5?% vs 35.7?%, χ (2)?=?3.939, P?
机译:最近的研究表明,弥散性大B细胞淋巴瘤(DLBCL)可以通过免疫组织化学染色分为生发中心B细胞样(GCB)和非GCB表型。这项研究的目的是调查中国原发性胃DLBCL患者的免疫表型分类与临床病理特征的相关性,以进一步了解这种疾病。对73例经组织病理学诊断为原发性胃DLBCL的患者进行了研究。使用EnVision方法进行免疫组织化学以检测CD10,Bcl-6和MUM1的表达。使用Kaplan-Meier方法,log-rank检验和χ(2)检验分析临床病理特征和随访数据。在21.9%(16/73)的患者中观察到CD10的表达,在72.6%(53/73)的患者中观察到Bcl-6,在74.0%(54/73)的患者中观察到MUM1。根据这些数据,其中32.9%(24/73)的病例属于GCB亚型,67.1%(49/73)的病例属于非GCB亚型。 GCB组和非GCB组在肿瘤大小和局部淋巴结转移方面存在显着差异(P <0.05)。 GCB组的并发症发生率(4.2%)比非GCB组的并发症发生率低(18.4%)。但是,该差异不显着(P≥0.05)。生存分析表明,与非GCB组相比,GCB组患者的5年生存率增加(58.5 %% vs 35.7%,χ(2)^ = 3.939,P <0.05) 。接受R-CHOP化疗的患者的5年生存率显着高于CHOP组(74.7%vs 37.5%,χ(2)= 4.185,P <0.05)。发现原发性胃DLBCL的免疫表型分类与肿瘤的大小和局部淋巴结转移密切相关,具有预后意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号